Monthly Prescribing Reference

Prograf approved for combination therapy with mycophenolate mofetil (MMF) in kidney transplant recipients

The FDA has approved Prograf (tacrolimus, from Astellas) in conjunction with mycophenolate mofetil (MMF) for the prevention of organ rejection in kidney transplant recipients. This approval was based ...
Yahoo

The bottles of two recalled drugs might have empty capsules. That can cause death

Two drugs have been recalled because their capsules might be empty — and the consequences could be deadly. Astellas Pharma’s Prograf gets prescribed after heart, liver, kidney or lung transplants.
Houston Chronicle

Two medications used by transplant patients recalled because bottles might contain empty capsules

Bottles of two medications that prevent the body's rejection of transplanted organs were recalled because the capsules may be empty. Astellas Pharma US, Inc. announced this week it is voluntarily ...
Nasdaq

U.S. Food and Drug Administration Expands Indication for PROGRAF® for Prevention of Organ Rejection in Adult and Pediatric Lung Transplant Recipients

NORTHBROOK, Ill., July 20, 2021 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") announced that the U.S. Food and Drug Administration (FDA) has ...
Monthly Prescribing Reference

Prograf Injection

Tacrolimus 5mg/mL; soln for IV infusion after dilution; contains polyoxyl 60 hydrogenated castor oil. Give at least 6hrs after transplantation if unable to tolerate oral caps. Heart: initially ...